BDO provided Corporate Finance advice to Kester Capital on their investment in Factory-CRO. Headquartered in The Netherlands, Factory-CRO is a leading, full service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologicals, and device-drug combinations internationally.
Kester Capital will become a significant shareholder in Factory-CRO and support the business’ growth, both organically and by acquisition, as it looks to build on its unique expertise and impressive track record.
"The BDO team provided invaluable assistance with their deep sector expertise and network. We look forward to continuing to work with them in this exciting sector".
Adam Maidment, Partner, Kester Capital